Women could be facing a postcode lottery for HRT with those in affluent areas having better access, menopause campaigners warn
NHS prescribing data indicates that Cornwall and the Scilly Isles, along with Devon, Somerset, Dorset and Gloucestershire, have better provision of HRT. (Source: the Mail online | Health)
Source: the Mail online | Health - December 27, 2023 Category: Consumer Health News Source Type: news
Consumer Health: What does 'male menopause' mean?
Hormone changes are a natural part of aging, but the experience is different for men and women. Unlike the more dramatic plunge that occurs in women during menopause, sex hormone changes in men occur gradually. This is sometimes called male menopause. For women, menopause marks the end of their menstrual cycles, whether by naturally declining reproductive hormones, surgical removal of the ovaries, changes caused by chemotherapy or radiation therapy, or a conditional called primary ovarian… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 25, 2023 Category: Databases & Libraries Source Type: news
Pill to fight hot flushes approved for use in UK
A drug that tackles hot flushes in menopausal women has been approved for use in the UK. (Source: Daily Express - Health)
Source: Daily Express - Health - December 22, 2023 Category: Consumer Health News Source Type: news
Older weight loss drugs are making a comeback as Zepbound, Wegovy remain out of reach for many
For Christy Nguyen, menopause hit just as the Covid-19 pandemic did. With both, she said, came unwanted weight gain. “I had gained 30 pounds in about two years, and so I was sort of desperate to find something” to help with weight loss, the 56-year-old mother of two said. She’d tried…#christynguyen #weightwatchers #glp1 #jodydushay #dushay #epicresearch #ozempic #boston #elililly #mounjaro (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2023 Category: Consumer Health News Source Type: news
The Secret to Living Longer Starts With Menopause
(Source: Reuters: Health)
Source: Reuters: Health - December 20, 2023 Category: Consumer Health News Source Type: news
The Biggest Breakthrough in Longevity May Start With Menopause
(Source: Reuters: Health)
Source: Reuters: Health - December 20, 2023 Category: Consumer Health News Source Type: news
The good news for women: a drug to limit hot flushes. The bad: it could cost you £430 a month | Devi Sridhar
Veoza reduces the severity of this common menopausal symptom. But at that high cost, only the wealthy will gain just nowAfter decades of neglect, menopause and the impact it has on women ’s life quality is becoming a major focus of pharmaceutical research. Hence the excitement this week about a new, potentially life-changing, drug.Part of this is the growing recognition of what a huge market it is: theNHS estimates that 13 million women are currently peri- or menopausal in the UK, which is roughly a third of the female population. The most common symptom is hot flushes, which, in addition to fatigue, mood swings and musc...
Source: Guardian Unlimited Science - December 19, 2023 Category: Science Authors: Devi Sridhar Tags: Menopause Society Science Medical research UK news Women's health Source Type: news
Menopause drug to treat hot flushes and night sweats gets MHRA approval
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of fezolinetant – manufactured under the brand name of Veoza – to treat hot flushes and night sweats associated with the menopause. Julian Beach, interim executive director of healthcare quality and access at the MHRA, said the organisation was pleased to approve the... Read moreThe post Menopause drug to treat hot flushes and night sweats gets MHRA approval appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - December 19, 2023 Category: Nursing Authors: Megan Ford Tags: Clinical Latest news Women's health Source Type: news
'Game changing' drug to prevent menopause hot flushes approved in UK
The drug tackles hot flushes and night sweats and women who took part in a clinical trial also said the drug helped them sleep better. (Source: Daily Express - Health)
Source: Daily Express - Health - December 18, 2023 Category: Consumer Health News Source Type: news
‘Gamechanging’ drug to prevent hot flushes wins approval in UK
Veoza, also known as fezolinetant, is prescription-only and will be available privately from JanuaryA “gamechanging” drug that prevents hot flushes and could benefit hundreds of thousands of women has been approved for use in the UK.The green light for Veoza, also known as fezolinetant, comes after the US regulator, the Food and Drug Administration, authorised it for use in America in May.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 18, 2023 Category: Science Authors: Andrew Gregory Health editor Tags: Women's health Menopause Society UK news Pharmaceuticals industry Source Type: news
Hot-flushes menopause drug Veoza approved in UK
Veoza, or fezolinetant, a non-hormonal daily pill, works on the brain's temperature-control centre. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 18, 2023 Category: Consumer Health News Source Type: news
Assessing menopause symptoms in women with traumatic brain injury: the development and initial testing of a new scale - Kalpakjian CZ, Hanks R, Quint EH, Millis S, Sander AM, Lequerica AH, Bushnik T, Brunner R, Rapport L.
With greater survival rates after catastrophic injury, more women with traumatic brain injury (TBI) are living longer than ever. However, knowledge about this transition in these women is largely unexamined and there are no scales that have been developed ... (Source: SafetyLit)
Source: SafetyLit - December 18, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Blockbuster menopause drug which fights hot flushes without HRT is approved for use in the UK
Fezolinetant could be transformative in tackling symptoms of the menopause for women who cannot use, or do not wish to take, hormone replacement therapy. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2023 Category: Consumer Health News Source Type: news
Drug which fights hot flushes without HRT is approved for use in the UK
Fezolinetant could be transformative in tackling symptoms of the menopause for women who cannot use, or do not wish to take, hormone replacement therapy. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2023 Category: Consumer Health News Source Type: news
Breakthrough study finds exercise slashes risk of breast cancer in pre-menopausal women
The Institute of Cancer Research has found that increased exercise lowers pre-menopausal women's risk of getting breast cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - December 12, 2023 Category: Consumer Health News Source Type: news
